share_log

6-K: FDA Approves Expansion of Glaxosmithkline Rsv Vaccine to Adults 50 to 59 Years of Age

SEC announcement ·  Jun 10 18:33
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.